Eye Cancer Treatment WVU (IMAGE) West Virginia University Caption Osama Elzamzamy—a graduate research assistant in the WVU Cancer Institute—conducts work in Lori Hazlehurst’s laboratory. Hazlehurst is the Cancer Institute’s associate director of basic research and a professor in the School of Pharmacy. She and her colleague Mark McLaughlin—a researcher with the Cancer Institute and School of Pharmacy professor—co-founded the company Modulation Therapeutics Inc., which recently received its first investigational new drug application from the Food and Drug Administration. Credit WVU Photo Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.